20 June 2013
Keywords: systemix, trials, begun, phase, i/ii, trial, its
Article | 12 June 1995
SyStemix has begun a Phase I/II trial of its hematopoietic stem cell
transplants to support multiple myeloma patients undergoing
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
19 June 2013
© 2013 thepharmaletter.com